Kestra Medical
Facts
- HQ
- Kirkland, Wash.
- Sectors
- Medical Technology, Healthcare, Cardiac Monitoring, Therapeutic Devices
- Stage
- Public
2026 GeekWire Awards Celebrate Seattle Tech Scene with Over 300 Attendees and Winners Including Carbon Robotics, HouseWhisper AI, and Omeros
The 2026 GeekWire Awards celebrated Seattle's vibrant tech community with over 300 attendees honoring top startups, founders, and leaders across multiple categories at Showbox SoDo. The event highlighted Seattle as a hub for innovation with winners like Carbon Robotics, HouseWhisper AI, and Omeros recognized for their contributions.
OpenAI's $1.1B Statsig Acquisition and Other Billion-Dollar Deals Finalists for 2026 GeekWire Deal of the Year
The 2026 GeekWire Awards feature finalists including billion-dollar deals by OpenAI and others, a rare Seattle-area IPO, and a $5 billion mega-round, all recognized for their significant impact on Northwest tech. Voting for the Deal of the Year, which highlights key transactions in innovation, runs through April 16.
2025 Tech Year-End: AI Boom, $80 Billion Bets, and Seattle's Shifting Job Landscape Highlight Industry's Brutal Realities
The year 2025 was pivotal in technology history, marked by AI's rapid ascent, significant investments, tech industry layoffs, and evolving job impacts, particularly in Seattle. Key perspectives from Bill Gates and Satya Nadella highlight AI's transformative nature and the industry's complex challenges and opportunities.
Bala Vishwanath Named SeekOut CMO; Zillow’s Chad Cohen and Zulily’s Darrell Cavens Join Grindr and Match Group Boards
Bala Vishwanath joined SeekOut as chief marketing officer, while former Zillow CFO Chad Cohen and ex-Zulily CEO Darrell Cavens joined the boards of Grindr and Match Group, respectively. These appointments highlight leadership changes in prominent Seattle-area tech and dating companies.
Kestra Medical Technologies Raises $202M in IPO, Shares Price at $17 and Begin Trading at $22.95 on Nasdaq
Kestra Medical Technologies raised $202 million in its IPO by pricing shares at $17, above the expected range, with shares beginning trading at $22.95 on Nasdaq under ticker KMTS. The company, founded in 2014, produces wearable cardiac monitoring devices used in over 550 hospitals.
Seattle Biotech Tune Therapeutics Raises $175M to Advance Epigenetic Editing Trials for Chronic Hepatitis B
Seattle-based biotech startup Tune Therapeutics raised $175 million to support clinical trials of its epigenetic editing treatments for chronic Hepatitis B. The funding will aid development of therapies that control gene expression without altering DNA, leveraging technology developed at Duke University.
Kestra Medical Technologies Raises $196M to Expand Commercialization of FDA-Approved Wearable Defibrillator
Kestra Medical Technologies raised $196 million to accelerate commercialization of its FDA-approved Wearable Cardioverter Defibrillator, designed to meet female cardiac patients' needs. The funding round was co-led by Andera Partners, Ally Bridge Group, Longitude Capital, and Omega Funds, increasing total funding to $496 million.
People
-
Brian Webster Executive, President and CEO
